This study showed that in a cervical cancer mice model [30] vaccination with three doses of irradiated TC-1/cGM-CSF vaccine regressed tumor growth and enhanced the overall survival of mice compared with that of mice receiving five doses of irradiated TC-1/cGM-CSF vaccine. The gene discussed is CSF2; the disease is neoplasm.